brexit-istock-537519806_andrewlinscott

andrewlinscott / iStockphoto.com

16 August 2019Big PharmaSaman Javed

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

Several pharma bodies have signed non-disclosure agreements (NDAs) which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

More on this story

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

More on this story

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims